<DOC>
	<DOCNO>NCT02528760</DOCNO>
	<brief_summary>1 . All patient chronic liver disease admit ICU ( Intensive Care Unit ) screen . 2 . Patients fulfil criterion fee intolerance include study . 3 . Patients undergo routine biochemical hematological test include CBC , KFT , LFT , PT/INR , electrolytes baseline daily along ABG ( Arterial Blood gas ) analysis . 4 . Patients ascites tested presence absence SBP ( Spontaneous Bacterial Peritonitis ) . 5 . Cultures send base clinical parameter patient . 6 . All correctable cause intra abdominal hypertension correct include electrolyte imbalance , grade III ascites , intra abdominal infection . 7 . Symptoms- Absent bowel sound ( BS ) = BS detect auscultation . Vomiting/regurgitation= visible regurgitation gastric content ; Diarrhoea= liquid stool &gt; =3 times/day ; Bowel distension= suspect clinically radiologically confirm ; Large gastric residual volume ( GRV ) &gt; =500 ml/24 h single day &gt; 200ml time day . 8 . Per abdomen finding check daily include presence bowel sound , tenderness , development abdominal distension , abdominal girth monitor abdominal pressure monitoring . 9 . Patients develop feed intolerance include . 10 . Feed intolerance define per study definition ( 3 5 symptom ) . 11 . Measurement GRV ( Gastric residual volume ) do 4 hourly interval . 12 . Methods measure GRV either gravity drainage connect gastric tube drainage bag 10min manual aspiration content use 50ml syringe . 13 . Once feed intolerance develop every 6 hourly intra abdominal pressure monitor abdominal girth monitor do ( 24 ) 14 . Intra bladder pressure measure use Foleys manometer technique ( 25 ) . 15 . Pressure measure cm water convert mm Hg . 16 . X ray abdomen supine look bowel distension , define 3 cm small bowel 5 cm large bowel . 17 . Development intra abdominal hypertension base intra abdominal pressure . 18 . Patient stratify accord grade intra-abdominal hypertension . 19 . After correction correctable cause , fee intolerance persists , patient randomize block randomization method 3 arm , metaclopromide group , erythromycin group placebo group . 20 . Daily assessment bowel sound , abdominal pressure , abdominal girth every 6 hourly gastric residual volume note every 4 hourly . 21 . Response therapy assess 24 hour arm . 22 . Response assess resolution feed intolerance initiation entral nutrition . 23 . Metoclopromide give 10mg iv 8 hourly . 24 . Erythromycin give 70mg iv 12 hourly ( 26 ) . 25 . Placebo arm receive normal saline 10ml syring twice daily . 26 . After 24 hour treatment symptom resolve rescue treatment give arm may include continuation prokinetics , add prokinetic , flatus tube insertion bowel decompression , upgradation antibiotic search cause , per patient response . 27 . Therapy continue total duration 72 hour . 28 . If response 72 hour , study stop . 29 . If patient responds give treatment , study continue total duration 7 day . 30 . Assessment continue arm maximum period 7 day .</brief_summary>
	<brief_title>To Determine Role Prokinetics Feed Intolerance Critically Ill Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<criteria>1 . Patients develop new onset feed intolerance enteral nutrition 1 . Any patient current past surgical abdomen include mechanical obstruction , mesenteric ischemia , perforation require abdominal surgery . 2 . Patients receive enteral nutrition gastrostomy jejunostomy . 3 . Patients , prokinetics contraindicate allergic . 4 . Patients receive prokinetic one day prior start enteral feeding . 5 . Patients uncontrolled sepsis DIC . 6 . Requirement two vasopressor . 7 . Organ failure require high inotropic support . 8 . Advanced cardiopulmonary disease , prior history arrhythmia , structural heart disease . 9 . History traumatic brain injury , raise intracranial pressure , history myasthenia gravis . 10 . Endocronolgic illness : Hypothyroidism , hypoparathyroidism 11 . Connective tissue disease ( systemic sclerosis , dermatomyositis polymyositis , systemic lupus erythematosis , amyloidosis ) . 12 . Known case diabetes diabetic gastroparesis 13 . Pregnancy 14 . Patients concerned family member fail give consent study enrollment 15 . Age le 18 year 70 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>